Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-18 1:30 pm Sale | 2022-08-12 | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 1,760,000 4.800% | -129,127 (-6.84%) | Filing History |
| 2022-08-16 12:20 pm Purchase | 2022-08-12 | 13D | MIRUM PHARMACEUTICALS INC MIRM | Frazier Life Sciences IX, L.P. | 3,861,781 10.500% | 294,869 (+8.27%) | Filing History |
| 2022-08-02 3:31 pm Sale | 2022-08-01 | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 1,889,127 5.900% | -310,873 (-14.13%) | Filing History |
| 2022-04-08 2:49 pm Sale | 2022-03-31 | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,200,000 6.900% | -245,147 (-10.03%) | Filing History |
| 2022-02-14 6:23 pm Purchase | 2021-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,538,814 5.020% | 42,289 (+2.83%) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | MIRUM PHARMACEUTICALS INC MIRM | James E. Flynn | 3,282,912 10.720% | -166,000 (-4.81%) | Filing History |
| 2021-10-25 06:07 am Sale | 2021-10-19 | 13G | MIRUM PHARMACEUTICALS INC MIRM | TAKEDA PHARMACEUTICAL CO LTD TAK | 530,562 1.700% | -1,328,589 (-71.46%) | Filing History |
| 2021-08-24 4:32 pm Unchanged | 2021-08-19 | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 8.000% | 0 (Unchanged) | Filing History |